| Members |
targetComponentId |
| koriongonadotropin alfa 10 000 IE, pulver och vätska till injektionslösning, ampull |
Choriogonadotropin alfa only product in parenteral dose form |
| koriongonadotropin alfa 10 000 IE, pulver till injektionsvätska, lösning, ampull |
Choriogonadotropin alfa only product in parenteral dose form |
| koriongonadotropin alfa 1 500 IE, pulver och vätska till injektionslösning, ampull |
Choriogonadotropin alfa only product in parenteral dose form |
| koriongonadotropin alfa 1 500 IE, pulver till injektionsvätska, lösning, ampull |
Choriogonadotropin alfa only product in parenteral dose form |
| koriongonadotropin alfa 2 000 IE, pulver och vätska till injektionslösning, ampull |
Choriogonadotropin alfa only product in parenteral dose form |
| koriongonadotropin alfa 2 000 IE, pulver till injektionsvätska, lösning, ampull |
Choriogonadotropin alfa only product in parenteral dose form |
| koriongonadotropin alfa 5 000 IE, pulver och vätska till injektionslösning, ampull |
Product containing only choriogonadotropin (medicinal product) |
| koriongonadotropin alfa 5 000 IE, pulver till injektionsvätska, lösning, ampull |
Product containing only choriogonadotropin (medicinal product) |
| meningiom i plexus choroideus |
Meningioma, chordoid (morphologic abnormality) |
| papillom i plexus choroideus |
Benign choroid plexus papilloma (morphologic abnormality) |
| koroideremi samtidig med hypopituitarism |
Choroideremia with deafness and obesity syndrome (disorder) |
| kromfosfat (^32^P) 15 millicurie, injektionsvätska, suspension, ampull 10 ml |
Chromic phosphate (32-P) only product in parenteral dose form |
| Chromic phosphate, p-32 7.0mil/mL injection |
Chromic phosphate (32-P) only product in parenteral dose form |
| Chromic phosphate[32P] 185MBq/mL injection |
Chromic phosphate (32-P) only product in parenteral dose form |
| kromfosfat (^32^P) 185 MBq/ml, pulver till injektionsvätska, flaska |
Chromic phosphate (32-P) only product in parenteral dose form |
| Chromobacterium fluviatile |
Iodobacter fluviatilis |
| Chromobacterium lividum |
Janthinobacterium lividum (organism) |
| kromosom ersatt av ring- eller dicentrisk kromosom |
Ring chromosome |
| Chronic active type A viral hepatitis |
Viral hepatitis, type A |
| Chronic aggressive type A viral hepatitis |
Viral hepatitis, type A |
| Chronic angle-closure glaucoma |
Chronic angle-closure glaucoma |
| Chronic antritis |
Chronic maxillary sinusitis |
| Chronic cyclitis |
Intermediate uveitis |
| Chronic erythremia |
Polycythemia vera (clinical) |
| Chronic erythremia |
Polycythemia vera |
| Chronic erythremia |
Polycythemia vera (clinical) |
| Chronic erythremia in remission |
Polycythemia vera (clinical) |
| Chronic female pelvic peritonitis |
Chronic inflammation of pelvic peritoneum (disorder) |
| Chronic infection |
Chronic infectious disease |
| klinisk handläggningsplan för kronisk njursjukdom |
Chronic kidney disease clinical management plan (record artifact) |
| kronisk leukemi, kategori |
Chronic leukemia (morphologic abnormality) |
| kronisk lymfatisk leukemi, kategori |
B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma |
| Chronic lymphoproliferative disease |
Lymphoproliferation of uncertain behavior (morphologic abnormality) |
| Chronic monocytic leukemia |
Myeloid leukaemia |
| Chronic monocytic leukemia in remission |
Myeloid leukemia in remission |
| kronisk myeloisk leukemi |
Chronic myeloid leukemia (morphologic abnormality) |
| kronisk myeloisk leukemi, kategori |
Chronic myeloid leukemia (morphologic abnormality) |
| Chronic myelomonocytic leukemia |
Chronic myelomonocytic leukaemia |
| kronisk myeloproliferativ sjukdom |
Malignant myeloproliferative neoplasm |
| kronisk myeloproliferativ sjukdom, morfologi |
Malignant myeloproliferative neoplasm |
| kronisk nekrotiserande lungaspergillos |
Subacute invasive pulmonary aspergillosis (disorder) |
| Chronic neurogenic ulcer of skin |
Neurogenic ulcer |
| kronisk non-A-non-B-hepatit |
Chronic viral hepatitis |
| kronisk ospecifik lungsjukdom |
Chronic lung disease (disorder) |
| kroniskt obstruktiv lungsjukdom med astma |
Asthma-chronic obstructive pulmonary disease overlap syndrome |
| klinisk handläggningsplan för kroniskt obstruktiv lungsjukdom |
Chronic obstructive pulmonary disease clinical management plan (record artifact) |
| Chronic osteomyelitis of other specific site, NEC |
Chronic osteomyelitis |
| Chronic persistent type A viral hepatitis |
Viral hepatitis, type A |
| kronisk polyartikulär juvenil reumatoid artrit |
Polyarticular juvenile idiopathic arthritis |
| Chronic postrheumatic arthropathy |
Jaccoud's syndrome |
| Chronic pyelonephritis |
Chronic pyelonephritis |
| Chronic secretory otitis media |
Chronic mucoid otitis media |
| Chronic trophic ulcer of other specified site |
Chronic trophic ulcer of skin |
| Chronic type A viral hepatitis |
Viral hepatitis, type A |
| Chronic ulcer of other specified site |
Chronic ulcer of skin (disorder) |
| Chronic uremia |
Chronic renal failure |
| kronisk gul leveratrofi |
Chronic necrosis of liver |
| Chronobiologic disorder |
Abnormal chronobiologic state (finding) |
| Chryseobacterium meningosepticum |
Elizabethkingia meningoseptica (organism) |
| Chryseobacterium miricola |
Elizabethkingia miricola (organism) |
| /// Chryseobacterium scopthalmum |
Chryseobacterium scophthalmum (organism) |
| Chryseomonasart |
Pseudomonas |
| Chudley-Lowry-Hoars syndrom |
Alpha thalassemia X-linked intellectual disability syndrome (disorder) |
| kymopapainextrakt |
Product containing chymopapain (medicinal product) |
| ciklesonid 160 mikrogram, inhalator |
Product containing only ciclesonide in pulmonary dose form (medicinal product form) |
| ciklesonid 80 mikrogram, inhalator |
Product containing only ciclesonide in pulmonary dose form (medicinal product form) |
| ciklopirox 0,77 %, suspension för lokalt bruk |
Product containing precisely ciclopirox (as ciclopirox olamine) 7.7 milligram/1 milliliter conventional release cutaneous lotion (clinical drug) |
| ciklopiroxolamin 8 %, lösning |
Product containing precisely ciclopirox 80 milligram/1 milliliter conventional release cutaneous solution (clinical drug) |
| cidofovir 75 mg/ml, infusionskoncentrat, flaska 5 ml |
Cidofovir 75 mg/mL solution for injection |
| Cidofovir 75mg/mL injection |
Cidofovir 75 mg/mL solution for injection |
| Cidofovir 75mg/mL injection solution 5mL vial |
Cidofovir 75 mg/mL solution for injection |
| Cigarette cough |
Smokers' cough |
| Ciguatera |
Ciguatoxin causing toxic effect |
| cilazaprilallergi |
Non-allergic hypersensitivity to cilazapril (finding) |
| Cilioretinal artery sparing |
Cilioretinal artery sparing (finding) |
| Cimetidine hydrochloride 300mg/50 mL injection |
Product containing precisely cimetidine 6 milligram/1 milliliter conventional release solution for injection (clinical drug) |
| cimetidinhydroklorid 300 mg/50 ml (0,9 %), infusionsvätska, lösning, påse 50 ml |
Product containing precisely cimetidine 6 milligram/1 milliliter conventional release solution for injection (clinical drug) |
| cimetidinhydroklorid 300 mg/50 ml (0,9 %), intravenös vätska, lösning, påse 50 ml |
Product containing precisely cimetidine 6 milligram/1 milliliter conventional release solution for injection (clinical drug) |
| ciprofloxacin 0,2 % + hydrokortison 1 %, lösning, för användning i öra |
Product containing precisely ciprofloxacin (as ciprofloxacin hydrochloride) 2 milligram/1 milliliter and hydrocortisone 10 milligram/1 milliliter conventional release ear suspension (clinical drug) |
| ciprofloxacin 1 000 mg, tablett med modifierad frisättning |
Ciprofloxacin only product in oral dose form |
| ciprofloxacin 1 000 mg, depåtablett |
Ciprofloxacin only product in oral dose form |
| Ciprofloxacin 200mg solution |
Ciprofloxacin (as ciprofloxacin lactate) 2 mg/mL solution for injection |
| Ciprofloxacin 200mg/100mL |
Ciprofloxacin (as ciprofloxacin lactate) 2 mg/mL solution for injection |
| ciprofloxacin 200 mg/100 ml, intravenös injektionsvätska, lösning, färdig blandning i påse 100 ml |
Ciprofloxacin (as ciprofloxacin lactate) 2 mg/mL solution for injection |
| Ciprofloxacin 200mg/bag injection |
Ciprofloxacin (as ciprofloxacin lactate) 2 mg/mL solution for injection |
| Ciprofloxacin 2mg/mL |
Ciprofloxacin (as ciprofloxacin lactate) 2 mg/mL solution for injection |
| ciprofloxacin 2 mg/ml, infusionsvätska, lösning, flaska 200 ml |
Ciprofloxacin (as ciprofloxacin lactate) 2 mg/mL solution for injection |
| ciprofloxacin 2 mg/ml, infusionsvätska, lösning, flaska 50 ml |
Ciprofloxacin (as ciprofloxacin lactate) 2 mg/mL solution for injection |
| ciprofloxacin 500 mg, tablett med modifierad frisättning |
Ciprofloxacin only product in oral dose form |
| ciprofloxacin 500 mg, depåtablett |
Ciprofloxacin only product in oral dose form |
| Ciprofloxacin hydrochloride + hydrocortisone 2.329mg/10mg suspension |
Product containing precisely ciprofloxacin (as ciprofloxacin hydrochloride) 2 milligram/1 milliliter and hydrocortisone 10 milligram/1 milliliter conventional release ear suspension (clinical drug) |
| Cisapride 1mg/mL suspension |
Cisapride 1 mg/mL oral suspension |
| cisplatin 50 mg, pulver till infusionsvätska, lösning, flaska |
Product containing precisely cisplatin 50 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
| Cisplatin 50mg/vial powder for injection |
Product containing precisely cisplatin 50 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
| citalopramhydrobromid 10 mg/5 ml, lösning |
Product containing precisely citalopram (as citalopram hydrobromide) 2 milligram/1 milliliter conventional release oral solution (clinical drug) |
| citrat 6,5 %, ögondroppar |
Citric acid only product |
| citrat 6,5 %, ögondroppar utan konserveringsmedel |
Citric acid only product |
| citratallergi |
Allergy to citric acid (finding) |
| citronsyra 334 mg + kaliumcitrat 550 mg + natriumcitrat 500 mg, sirap |
Product containing precisely citric acid 66.8 milligram/1 milliliter and potassium citrate 110 milligram/1 milliliter and sodium citrate 100 milligram/1 milliliter conventional release oral solution (clinical drug) |
| citronsyramonohydrat 334 mg + kaliumcitrat 550 mg + natriumcitrat 500 mg, sirap |
Product containing precisely citric acid 66.8 milligram/1 milliliter and potassium citrate 110 milligram/1 milliliter and sodium citrate 100 milligram/1 milliliter conventional release oral solution (clinical drug) |
| citronsyramonohydrat 334 mg + kaliumcitrat 550 mg + natriumcitratdihydrat 500 mg, sirap |
Product containing precisely citric acid 66.8 milligram/1 milliliter and potassium citrate 110 milligram/1 milliliter and sodium citrate 100 milligram/1 milliliter conventional release oral solution (clinical drug) |